Clinical and Laboratory Markers of The Development and Progression of Renal Damage in Patients with Systemic Scleroderma
International Journal of Medical Science and Dental Health · 01.10.2026 · 8-12
DOI: 10.55640/ijmsdh-spe-02 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Science and Dental Health, online erschienen am 01.10.2026. Verfasst von Yusupov Ilkhom Kobuljonovich.
Abstract (Originalsprache)
To Studying the clinical and laboratory signs of the development and progression of kidney damage in patients with systemic scleroderma is an urgent scientific and practical task. Investigating the clinical and laboratory markers of scleroderma nephropathy not only allows for a deeper understanding of the mechanisms of kidney damage in systemic scleroderma, but also improves early diagnosis, disease activity monitoring, disease course prediction, and the individualization of therapeutic and preventive measures.
Zitieren
APA
Kobuljonovich, Y. I. (2026). Clinical and Laboratory Markers of The Development and Progression of Renal Damage in Patients with Systemic Scleroderma. International Journal of Medical Science and Dental Health, 8-12. https://doi.org/10.55640/ijmsdh-spe-02
Vancouver
Kobuljonovich YI. Clinical and Laboratory Markers of The Development and Progression of Renal Damage in Patients with Systemic Scleroderma. International Journal of Medical Science and Dental Health. 2026:8-12. doi:10.55640/ijmsdh-spe-02
BibTeX
@article{Kobuljonovich2026,
author = {Kobuljonovich, Yusupov Ilkhom},
title = {Clinical and Laboratory Markers of The Development and Progression of Renal Damage in Patients with Systemic Scleroderma},
journal = {International Journal of Medical Science and Dental Health},
year = {2026},
pages = {8--12},
doi = {10.55640/ijmsdh-spe-02}
}
EUVIMED